JOURNAL OF CLINICAL SURGERY ›› 2022, Vol. 30 ›› Issue (5): 486-489.doi: 10.3969/j.issn.1005-6483.2022.05.024

Previous Articles     Next Articles

Differentiated expression and clinical significance of crystallin-alpha B in lung squamous cell carcinoma

  

  1. Department of Thoracic Surgery,the Fourth Affiliated Hospital of Nanjing Medical University,Nanjing 210000,China
  • Received:2022-04-10 Accepted:2022-04-10 Online:2022-05-20 Published:2022-06-20

Abstract: [Abstract] Objective To explore the expression of crystallinalpha B(CRYAB) in elderly lung squamous cell carcinoma(LUSC) and investigate the relationship between its expression and clinical characteristics of LUSC.Methods Twenty cases of cancer tissues and adjacent tissues of LUSC patients from January 2014 to December 2016 were selected for qPCR detection and immunohistochemistry analysis(IHC) in tissue microarrays(59 LUCC samples and corresponding non-cancerous samples) were performed to characterize CRYAB expression in LUSC.Cox regression and KaplanMeier survival analyses were carried out to evaluate the prognostic indicator of LUSC.Results qPCR test showed that the expression value of CRYAB mRNA in LUSC was (4.456±1.512),which was significantly higher than that in adjacent tissue (2.944±0.4907),and the difference was statistically significant(P<0.05).Immunohistochemical detection showed that the protein expression of CRYAB in LUSC was significantly higher than that in the adjacent control group(P<0.05).Moreover,the expression level of CRYAB protein in LUSC was significantly correlated to T status(P<0.05).Univatiate and multivariate analysis of Cox regression showed that CRYAB expression could be identified as an independent prognosis factors for LUSC(P<0.05).High expression of CRYAB suggests poor prognosis.ConclusionCRYAB is highly expressed in LUSC patients.The data suggest that CRYAB expression is associated with malignant phenotypes of LUSCC and it may serve as a novel prognostic factor for LUSC.

Key words: lung squamous cell carcinoma, crystallinalpha B, qPCR, immunohistochemistry analysis, prognosis

[1] LI Zongfu, CHEN Tieliang, DING Mei, et al. Analysis of the effect of rapid rehabilitation surgery on the nutritional status of patients undergoing laparoscopic-assisted pyloric sparing gastrectomy for early gastric cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(5): 433-436.
[2] RUAN Tian, LI Changsheng, YANG Zetian, et al. The effect of visceral pleural invasion on the survival of postoperative patients with stage ⅢA/N2 non-small cell lung cancer:SEER database analysis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(5): 448-452.
[3] YE Bin, XIANG Qiu, JIN Wenjie. Expression of forkhead box Q1 and CyclinD1 in non-small cell lung cancer and their relationship with clinicopathological features and prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(5): 453-458.
[4] YANG Heng, ZHANG Jun, GUO Qiang, et al. The potential value of HLA-DPB1 in lung adenocarcinoma was analyzed based on multi-database [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(4): 339-344.
[5] JIN Yi , WANG Xinyi, DU Runsen, et al. Decreased expression of hsa-mir-337 predicts poor prognosis in patients with breast cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(4): 345-348.
[6] WANG Pengyuan, SHANG Yichao, ZHENG Duo, et al. Prognostic analysis of pelvis and ureteral carcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(4): 368-371.
[7] LU Kaijin, SHEN Jiangfeng, JIA Weiguang. Effect of thoracoscopic modified recurrent laryngeal nerve lymph node dissection for esophageal cancer and its effect on patient prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(3): 257-260.
[8] SHEN Jian, LI Minzhe, DU Yanfu. Effect of central obesity on clinical efficacy of laparoscopic D2 radical gastrectomy for distal gastric cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(3): 261-265.
[9] LI Yuzhu, XIA Lianjie. Expression of Dickkopfrelated protein 2 in cancer tissues of patients with bladder cancer and its correlation with prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(3): 280-283.
[10] JI Jintao, KANG Bo, SU Yansheng. Relationship between prostate specific membrane antigen expression and clinicopathological features in prostate cancer patients and its prognostic value [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(2): 130-133.
[11] LI Yunlong, DU Zhenghua, ZHANG Huimin, et al. Clinical treatment and prognostic analysis of gastrointestinal pancreatic neuroendocrine neoplasm [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(2): 166-170.
[12] ZHANG Mingkun, WANG Zhe, YANG Liu, et al.. Analysis of prognostic factors and construction of prognostic models for mucinous breast cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(1): 44-50.
[13] SUN Zheng, QUE Haifeng, LOU Jian, et al.. Prognostic significance of nutritional risk index in stage Ⅳ gastric cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(1): 58-61.
[14] HU Xinyu, YAO Hui, XIA Dong, et al.. Expression of C3G in gastric cancer tissure and the relation to the clinical features [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(9): 848-852.
[15] JIANG Xiaoqin, LI Huizhen.. Safety and effectiveness study of simultaneous TURBT and TURP in treatment of non-muscle-invasive bladder cancer patients complicated by benign prostatic hyperplasia [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(9): 872-875.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 772 .
[2] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(10): 783 .
[3] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 816 .
[4] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 819 .
[5] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 821 .
[6] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 824 .
[7] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 831 .
[8] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 835 .
[9] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 839 .
[10] . [J]. JOURNAL OF CLINICAL SURGERY, 2016, 24(11): 844 .